ES2099820T3 - Procedimiento para la preparacion de trans-piperidina-2,5-dicarboxilatos. - Google Patents

Procedimiento para la preparacion de trans-piperidina-2,5-dicarboxilatos.

Info

Publication number
ES2099820T3
ES2099820T3 ES92904789T ES92904789T ES2099820T3 ES 2099820 T3 ES2099820 T3 ES 2099820T3 ES 92904789 T ES92904789 T ES 92904789T ES 92904789 T ES92904789 T ES 92904789T ES 2099820 T3 ES2099820 T3 ES 2099820T3
Authority
ES
Spain
Prior art keywords
preparation
dicarboxylates
piperidine
trans
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92904789T
Other languages
English (en)
Inventor
Frank J Urban
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2099820T3 publication Critical patent/ES2099820T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCESO PARA LA PREPARACION DE DICARBOXILATOS PERIDINA CIS-PIPERIDINA DINA TRANS ALQUIL (C1 C3).
ES92904789T 1991-02-27 1992-01-08 Procedimiento para la preparacion de trans-piperidina-2,5-dicarboxilatos. Expired - Lifetime ES2099820T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66172691A 1991-02-27 1991-02-27

Publications (1)

Publication Number Publication Date
ES2099820T3 true ES2099820T3 (es) 1997-06-01

Family

ID=24654845

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92904789T Expired - Lifetime ES2099820T3 (es) 1991-02-27 1992-01-08 Procedimiento para la preparacion de trans-piperidina-2,5-dicarboxilatos.

Country Status (13)

Country Link
US (2) US5326874A (es)
EP (2) EP0737683A1 (es)
JP (1) JPH0725736B2 (es)
AT (1) ATE150453T1 (es)
CA (2) CA2195622C (es)
DE (1) DE69218414T2 (es)
DK (1) DK0573464T3 (es)
ES (1) ES2099820T3 (es)
FI (2) FI933755A (es)
GR (1) GR3023381T3 (es)
IE (2) IE920599A1 (es)
PT (1) PT100159B (es)
WO (1) WO1992015561A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185449A (en) * 1991-02-27 1993-02-09 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
HUT77354A (hu) * 1994-09-30 1998-03-30 Pfizer Inc. 2,7-Szubsztituált oktahidro-1H-pirido[1,2-a]pirazin-származékok, ezeket tartalmazó gyógyszerkészítmények és intermedierek
USRE43932E1 (en) 1997-07-18 2013-01-15 Novartis Ag Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
GB0001447D0 (en) 2000-01-21 2000-03-08 Novartis Ag Organic compounds
KR20040011427A (ko) 2000-11-08 2004-02-05 신젠타 파티서페이션즈 아게 피롤카르복시아미드 및 피롤카르보티오아미드 및 그의농화학적 용도
EP4032892A4 (en) 2019-09-18 2023-10-18 Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. CAMPTOTHECIN DERIVATIVE AND CONJUGATE THEREOF
MX2024005831A (es) 2021-11-15 2024-07-09 Systimmune Inc Conjugado de anticuerpo biespecifico-farmaco de camptotecina y uso farmaceutico del mismo.
WO2023098889A1 (zh) 2021-12-03 2023-06-08 成都百利多特生物药业有限责任公司 抗人Trop2抗体-喜树碱类药物偶联物及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018767A (en) * 1975-05-22 1977-04-19 Bristol-Myers Company Anti-arrhythmic agents
US4401820A (en) * 1981-01-23 1983-08-30 Tanabe Seiyaku Co., Ltd. Process for racemizing optically active α-amino acids or a salt thereof
US4505911A (en) * 1983-10-13 1985-03-19 Mead Johnson & Company Isoindole diuretic derivatives, compositions and use
MX19222A (es) * 1989-01-23 1993-12-01 Pfizer Agentes ansioliticos bis-aza-biciclicos
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
US5185449A (en) * 1991-02-27 1993-02-09 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents

Also Published As

Publication number Publication date
US5489688A (en) 1996-02-06
IE920599A1 (en) 1992-09-09
FI933755A0 (fi) 1993-08-26
CA2101252C (en) 1998-02-17
US5326874A (en) 1994-07-05
WO1992015561A3 (en) 1993-01-07
JPH0725736B2 (ja) 1995-03-22
FI962768A0 (fi) 1996-07-05
CA2195622C (en) 1999-08-17
WO1992015561A2 (en) 1992-09-17
CA2195622A1 (en) 1992-08-28
JPH06500121A (ja) 1994-01-06
PT100159B (pt) 1999-07-30
EP0573464B1 (en) 1997-03-19
PT100159A (pt) 1993-05-31
EP0737683A1 (en) 1996-10-16
IE970704A1 (en) 2000-02-23
FI962768A (fi) 1996-07-05
ATE150453T1 (de) 1997-04-15
GR3023381T3 (en) 1997-08-29
DE69218414T2 (de) 1998-01-22
EP0573464A1 (en) 1993-12-15
FI933755A (fi) 1993-08-26
DE69218414D1 (de) 1997-04-24
DK0573464T3 (da) 1997-09-01
CA2101252A1 (en) 1992-08-28

Similar Documents

Publication Publication Date Title
ES2070660B1 (es) Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
FI903331A0 (fi) Substituerade kinazolinoner, vilka aer anvaendbara som angiotensin-ii-antagonister.
NO2006018I1 (no) Entekavir:(2-amino-1,9-dihydro-9Ä(1S,3R,4S)-4hydroksy-3-(hydroksymetyl)-2-metylencyklopentylÜ-6H-purin-6-on og hydrater derav, saerlig monohydrat
DK0776324T3 (da) Endothelin-antagonister
DK0444659T3 (da) Farmaceutisk opløsning indeholdende derivater af FK 506
DK506587A (da) Imidderivater
SE9100920D0 (sv) New active compounds
PE34996A1 (es) Nuevo derivado de pirrocarbazol
FI915194A0 (fi) Heteroaroylderivat av monocykliska b-laktamantibiotika.
ES2099820T3 (es) Procedimiento para la preparacion de trans-piperidina-2,5-dicarboxilatos.
DE69121259D1 (de) Beta-Lactam-Verbindungen und ihre Herstellung
ITMI931012A1 (it) Composti spiro-piranici dotati di caratteristiche fotocromatiche
FI892681A (fi) Nya jodade icke-joniska trijodbenzenfoereningar och dessa innehaollande kontrastmedel.
DE69932269D1 (de) Herstellung optisch aktiver Cyclohexylphenylglykolsäureester
ES2092112T3 (es) Agentes hipoglicemicos de tiazolidindiona.
FI932691A (fi) Nya benzyl- och benzhydrylalkoholer
SE8700566L (sv) Tetracykliska kinazolinoner
FI905664A0 (fi) Glutarsyraderivat och deras framstaellningsfoerfaranden.
ES2195309T3 (es) Derivados de tetrahidrofurano.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 573464

Country of ref document: ES